56 Results for "

hypoglycemic agent

" in MedChemExpress (MCE) Product Catalog:
Products (56)

56 Results for "hypoglycemic agent" in MCE Product Catalog:

Cat. No.: HY-114683
CAS No.: 105955-01-9
Purity:  99.71%
Target:  

TGF-beta/Smad

Research Areas:  

Cardiovascular Disease

KS370G is an orally active hypoglycemic and cardiovascular protective agent. KS370G improves left ventricular hypertrophy and function in pressure-overload mice heart. KS370G reduces renal obstructive nephropathy .
loading...
    loading...
Cat. No.: HY-120401
CAS No.: 1492-02-0
Synonyms: Desaglybuzole
Target:  

Insulin Receptor GCGR

Research Areas:  

Metabolic Disease

Glybuzole (Desaglybuzole) is an orally effective hypoglycemic agent. Glybuzole promotes insulin secretion by pancreatic β cells and inhibits glucagon secretion by pancreatic α cells. Glybuzole reduces blood glucose levels as well as arginine-stimulated plasma glucagon levels. Glybuzole can be used in diabetes-related research .
loading...
    loading...
Cat. No.: HY-128740
CAS No.: 31635-99-1
Mesoxalate sodium monohydrate is an orally active antidiabetic agent. Mesoxalate sodium monohydrate increases pancreatic insulin content. Mesoxalate sodium monohydrate reduces dietary hyperglycemia. Mesoxalate sodium monohydrate inhibits Epinephrine-induced hyperglycemia in rabbits and exacerbates Alloxan (HY-116823)-induced hypoglycemic convulsions. Mesoxalate sodium monohydrate exerts no antidiabetic effect in pancreatectomized dogs and fails to reduce the susceptibility of rabbits to Alloxan-induced diabetes. Mesoxalate sodium monohydrate can be used in diabetes-related research .
loading...
    loading...
Cat. No.: HY-114634
CAS No.: 473-90-5
Synonyms: Ketomalonic acid; Mesoxalic acid; Oxomalonic acid
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Mesoxalate (Ketomalonic acid) is an orally active antidiabetic agent. Mesoxalate increases pancreatic insulin content. Mesoxalate reduces dietary hyperglycemia. Mesoxalate inhibits Epinephrine-induced hyperglycemia in rabbits and exacerbates Alloxan (HY-116823)-induced hypoglycemic convulsions. Mesoxalate exerts no antidiabetic effect in pancreatectomized dogs and fails to reduce the susceptibility of rabbits to Alloxan-induced diabetes. Mesoxalate can be used in diabetes-related research .
loading...
    loading...
Cat. No.: HY-170692
Target:  

Akt PI3K NF-κB

Research Areas:  

Metabolic Disease

Hypoglycemic agent 3 (Compound H26), a derivative of corosolic acid, exhibits lipid-lowering and significant hypoglycemic effects and can be used as a hypoglycemic agent. Hypoglycemic agent 3 inhibits insulin resistance by targeting MCCC1 and can be used in the study of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-130003
CAS No.: 2253733-57-0
Target:  

Others

Research Areas:  

Metabolic Disease

Hypoglycemic agent 1 acts as a therapeutic and/or prophylactic agent for diabetes. Hypoglycemic agent 1 has an action for lowering blood sugar .
loading...
    loading...
Cat. No.: HY-15383
CAS No.: 5581-42-0
Purity:  98.43%
Research Areas:  

Metabolic Disease

Glyparamide is an orally active hypoglycemic compound that serves as an auxiliary active ingredient in anti-diabetic agents. Glyparamide can be used in combination with preparations of Rhodamnia cinerea extract and is applicable to the study of hyperglycemia-related disorders-specifically those involving carbohydrate metabolism disturbances-including Type 2 diabetes, metabolic syndrome, and postprandial hyperglycemia. Other notable hypoglycemic agents of significant interest include: Tolbutamide (HY-B0401), Chlorpropamide (HY-B1429), Metformin (HY-B0627), and Glimepiride (HY-B0104) .
loading...
    loading...
Cat. No.: HY-W540188
CAS No.: 21085-60-9
Synonyms: Ketomalonic acid calcium; Mesoxalic acid calcium; Oxomalonic acid calcium
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Calcium mesoxalate (Ketomalonic acid calcium) is an orally active antidiabetic agent. Calcium mesoxalate increases pancreatic insulin content. Calcium mesoxalate reduces dietary hyperglycemia. Calcium mesoxalate inhibits Epinephrine-induced hyperglycemia in rabbits and exacerbates Alloxan (HY-116823)-induced hypoglycemic convulsions. Calcium mesoxalate exerts no antidiabetic effect in pancreatectomized dogs and fails to reduce the susceptibility of rabbits to Alloxan-induced diabetes. Calcium mesoxalate can be used in diabetes-related research .
loading...
    loading...
Cat. No.: HY-180784
Hypoglycemic agent 4 (Compound 5b) is a tetrahydroacridine derivative with orally active hypoglycemic activity. Hypoglycemic agent 4 has a good binding affinity for the key diabetic targets: DPP-IV, SGLT1, and GLUT2. Hypoglycemic agent 4 can inhibit glucose diffusion. Hypoglycemic agent 4 can reduce fasting blood sugar in Streptozotocin (HY-13753)-induced diabetic rats and its effect is comparable to Gliclazide (HY-B0753). Hypoglycemic agent 4 can be used for research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-U00012
CAS No.: 451-71-8
Synonyms: SQ 15860; Serbose; Subose
Target:  

Others

Research Areas:  

Metabolic Disease

Glyhexamide is an effective hypoglycemic agent in adult diabetics.
loading...
    loading...
Cat. No.: HY-N7910R
CAS No.: 470-55-3
Stachyose (Standard) is the analytical standard of Stachyose. This product is intended for research and analytical applications. Stachyose, a kind of oligosaccharides, act as a hypoglycemic agent[1].
loading...
    loading...
Cat. No.: HY-N3613
CAS No.: 526-87-4
Conduritol A is a hypoglycemic agent which inhibits the absorption of glucose and can be extracted from Gymnema sylvestre .
loading...
    loading...
Cat. No.: HY-B0401S1
Tolbutamide- 13C is the 13C-labeled Tolbutamide. Tolbutamide is a first generation potassium channel blocker, sulfonylurea oral hypoglycemic agent.
loading...
    loading...
Cat. No.: HY-B1103R
CAS No.: 3168-01-2
Synonyms: (±)-Hydroxyhexamid (Standard)
Hydroxyhexamide (Standard) is an analytical standard for Hydroxyhexamide. This product is intended for research and analytical applications. Hydroxyhexamide is a pharmacologically active metabolite of Acetohexamide, used as a hypoglycemic agents.
loading...
    loading...
Cat. No.: HY-163652
CAS No.: 24455-58-1
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Glicetanile is an orally active hypoglycemic agent, that stimulates the release of insulin from pancreatic beta cells, and lowers the blood sugar. Glicetanile exhibits potential in ameliorating the type 2 diabetes .
loading...
    loading...
Cat. No.: HY-B0089A
CAS No.: 1221158-13-9
Synonyms: Bay-g 5421 sulfate
Acarbose (BAY g 5421) sulfate, antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose sulfate can potentiate the hypoglycemic effects of sulfonylureas or insulin .
loading...
    loading...
Cat. No.: HY-135670
CAS No.: 170376-12-2
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

Glycosidase-IN-1 (Compound 9) is a glycosidase inhibitor synthesized from D-mannose. Glycosidase-IN-1 be used to synthesize some immunosuppressive agents and β-glucosidase inhibitors. Glycosidase-IN-1 has hypoglycemic activity .
loading...
    loading...
Cat. No.: HY-121323R
CAS No.: 4430-36-8
Acarbose (Standard) is the analytical standard of Acarbose. This product is intended for research and analytical applications. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .
loading...
    loading...
Cat. No.: HY-B0089S
CAS No.: 1260619-60-0
Synonyms: BAY g 5421-d4
Acarbose-d4 (BAY g 5421-d4) is deuterium labeled Acarbose. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .
loading...
    loading...
Cat. No.: HY-148529R
CAS No.: 66529-17-7
Synonyms: (±)-DG5128 free base (Standard); DG5128 free base (Standard)
Midaglizole (Standard) is the analytical standard of Midaglizole. This product is intended for research and analytical applications. Midaglizole ((±)-DG5128 free base; DG5128 free base) is a potent α2-adrenoceptor antagonist. Midaglizole is a hypoglycemic agent. Midaglizole increases blood pressure and reduces blood glucose levels in vivo .
loading...
    loading...